Abstract The food-grade Lactococcus lactis is a potential vector to be used as a live vehicle for the delivery of heterologous proteins for vaccine and pharmaceutical purposes. We constructed a plasmid vector pSVac that harbors a 255-bp single-repeat sequence of the cell wall-binding protein region of the AcmA protein. The recombinant plasmid was transformed into Escherichia coli and expression of the gene fragment was driven by the T7 promoter of the plasmid. SDS-PAGE showed the presence of the putative AcmA′ fragment and this was confirmed by Western blot analysis. The protein was isolated and purified using a His-tag affinity column. When mixed with a culture of L. lactis MG1363, ELISA and immunofluorescence assays showed that the cell wall-binding fragment was anchored onto the outer surface of the bacteria. This indicated that the AcmA′ repeat unit retained the active site for binding onto the cell wall surface of the L. lactis cells. Stability assays showed that the fusion proteins (AcmA/ A1, AcmA/A3) were stably docked onto the surface for at least 5 days. The AcmA′ fragment was also shown to be able to strongly bind onto the cell surface of naturally occurring lactococcal strains and Lactobacillus and, with less strength, the cell surface of Bacillus sphericus. The new system designed for cell surface display of recombinant proteins on L. lactis was evaluated for the expression and display of A1 and A3 regions of the VP1 protein of enterovirus 71 (EV71). The A1 and A3 regions of the VP1 protein of EV71 were cloned upstream to the cell wall-binding domains of AcmA protein and successfully expressed as AcmA/A1 and AcmA/A3. Whole-cell ELISA showed the successful display of VP1 protein epitopes of EV71 on the surface of L. lactis. The success of the anchoring system developed in this study for docking the A1 and A3 epitopes of VP1 onto the surface of L. lactis cells opens up the possibilities of peptide and protein display for not only Lactococcus but also for other gram-positive bacteria. This novel way of displaying epitopes on the cell surface of L. lactis and other related organisms should be very useful in the delivery of vaccines and other useful proteins.
Introduction
The use of Lactococcus lactis as a vaccine vector is becoming increasingly important, due to its classification as a "generally regarded as safe" organism that is nonpathogenic and noncolonizing. Studies on the feeding of live lactococci to human volunteers have shown that the passage of this bacteria through the intestinal tract is transitory, without any evidence of colonization (Drouault et al. 1999) . Despite its lack of invasiveness, L. lactis has been shown to deliver heterologous antigens to the systemic and mucosal immune systems via mucosal routes (Steidler et al. 2000) .
Many studies have been carried out to evaluate the effect of antigen-presenting systems by gram-positive bacteria on the immune system. In some systems, the antigen is secreted or expressed intracellularly in the host cytoplasm (Wells et al. 1993) . In others, due to the advantages related to having a direct contact between the antigen and immune system, the development of systems to display the foreign antigens on the surface of bacterial cells is of particular interest (Norton et al. 1997; Gunneriusson et al. 1996; Ribeiro et al. 2002) .
N-Acetylmuraminidase AcmA is an autolysin of L. lactis which is required for cell separation and is responsible for cell lysis during the stationary phase (Buist et al. 1995) The major peptidoglycan hydrolase (AcmA) of L. lactis consists of three domains: the N-terminal signal sequence, followed by an active domain and a C-terminal membrane anchor. The acmA gene encodes a polypeptide of 437 amino acids with a deduced molecular weight of 46 kDa (Buist 1997) . Three repeated regions comprising 44 amino acids are present in the C-terminal domain of the protein.
These repeats are involved in bacterial cell wall binding and are separated by intervening sequences which are highly enriched with serine, threonine and asparagine residues (Buist 1997) . Only one of these repeats is sufficient for cell wall binding (Buist 1997) . Here, we report on the expression and purification of one unit of the AcmA C-terminal repeat fragment from a recombinant Escherichia coli and describe a novel display method of this cell wall-binding fragment with viral epitopes exposed on the cell surface of L. lactis, Lactobacillus and Bacillus sphericus.
Materials and methods

Microorganisms
E. coli TOP10 (Invitrogen, USA) was used as a cloning host.
) was used as the E. coli expression host. Lactococcus lactis MG1363 lac − prt − was the strain used to isolate the acmA gene. Other target strains used were L. lactis M22 isolated from cow's milk, Lactobacillus plantarum and B. sphericus S1, each isolated from chicken intestine and soil by members of the laboratory for other purposes. ; Invitrogen, USA), an E. coli vector, was used for cloning the acmA′ fragment. pRSETC (Amp R ; Invitrogen, USA), an expression vector for E. coli, was used for the cloning and expression of the cell wall protein fragment.
Culture conditions
Lactococcal cells were grown at 30°C in M17 broth (Oxoid) or M17 agar with 0.5% glucose as a standing culture. E. coli cells were grown at 37°C with agitation in LB broth. Whenever required, ampicillin (50 μg/ml) and chloramphenicol (35 μg/ml) were used for the recombinant E. coli cultures.
PCR primers and conditions
To amplify the acm′ unit sequence, primers acmAF1 and RNACMR2 were used. The acmAF1 primer was a 27-mer forward primer (5′-CTGCAGGACGGACGGAGCTTCTT CAGC-3′). RNACMR2 was a 32-mer reverse primer (5′-AAGCTTTTATGAACCACCTGAATTTGTAGAAG-3′). Primers A1F, A1R, A3F and A3R were used to amplify the N-terminal regions (A1, A3) of the VP1 gene. A1F was a 26-mer forward primer (5′-AATCTCGAGGAGAT AGAGTGGCAGAT-3′). A1R was a 30-mer reverse primer (5′-CGACTGCAGTCGTGTCTAATCATGCTCTC-3′). A3F was a 26-mer forward primer (5′-AATCTCGAGTGAGCA GTCATCGACTA-3′). A3R was a 33-mer forward primer (5′-CGACTGCAGGGTACCCTCAAGAGGGAGATCT AT-3′). The restriction enzyme recognition sites are in italics. A 25 μl reaction sample was prepared and PCR was carried out using the Mastercycler (Eppendorf, Germany). Samples were denatured at 95°C for 5 min and amplification was then carried out in 30 cycles of 94°C for 1 min, 55°C for 1 min and 72°C for 1 min; and after the last cycle the reaction was held at 72°C for 10 min.
Construction of plasmid pSVac and transformation into competent cells
A fragment containing the acmA′ gene was amplified by PCR with the acmAF1 and RNACMR2 primers, using the Lactococcus lactis MG1363 genomic DNA as template. The amplified 255-bp fragment was digested by PstI and HindIII, followed by ligation into the corresponding sites on plasmid pRSETC. The ligated DNA was transformed into E. coli cells by the heat-shock method (Sambrook et al. 1989) . Ampicillin-and chloramphenicol-resistant transformants were then selected, followed by plasmid extraction and restriction digestion analyses.
Cloning of the N-terminal regions (A1, A3) of the VP1 gene of EV71 into pSVac vector PCR amplifications of the A1 and A3 regions of the VP1 gene were performed using the A1F, A1R, A3F and A3R primers. A construct harboring the full-length cDNA of the VP1 gene was used as the template (a gift from Jane Cardosa). The amplified A1 and A3 regions were digested by XhoI and PstI, followed by ligation into the corresponding sites on plasmid pSVac. The ligated DNA was transformed into E. coli cells by the heat-shock method. Ampicillin-and chloramphenicol-resistant transformants were then selected, followed by plasmid extraction and restriction digestion analyses.
Expression studies by SDS-PAGE and Western blot SDS-PAGE of proteins was performed according to Laemmli (1970) using 10.0-12.5% polyacrylamide gels.
The E. coli strains were harvested by centrifugation at 2,000 g for 10 min. The pellet was resuspended in 100 μl of 2× sample buffer (3.55 ml of dH 2 O, 1.25 ml of 0.5 M Tris-HCl, pH 6.8, 2.5 ml of glycerol, 2 ml of 10% SDS, 0.2 ml of 0.5% bromophenol blue, 0.5 ml of β-mercaptoethanol) prior to boiling at 95°C for 5 min. After boiling, the supernatant was used as the SDS-PAGE sample. For Western blotting, the electrophoresed protein from the SDS-PAGE was transferred onto a polyvinylidene difluoride membrane by semi-dry blotter (Hoeffer-Pharmacia Biotech, UK). The membrane was then incubated in 1% blocking solution (Roche) for 1 h at room temperature with gentle agitation. Then, the membrane was incubated with primary mouse monoclonal anti-His antibody. The conjugated membrane was then washed three times with TBST (0.1% Tween 20 in 50 mM Tris, pH 7.5) before incubation with peroxidase-labeled secondary antibody (50 mU/ml in 0.5% blocking solution) for 60 min at room temperature with gentle agitation. After washing with TBST, the membrane was exposed to film for 20 min, and visualized.
Purification of recombinant protein fragment and binding to L. lactis Aliquots (10 ml) of cell culture were harvested after 2-3 h of induction. The cells were resuspended in 400 μl of 1×PBS and then lysed by a combination of lysozyme and glass beads. The crude homogenate was centrifuged at 10,000 g for 15 min and its supernatant applied to a Ni 2+ affinity column (Amresco, USA). The recombinant protein was eluted with 250 mM imidazole buffer and its concentration was calculated. The cells in 5 ml of exponentially growing L. lactis MG1363 were gently resuspended in 600 μl of fresh M17 broth after centrifugation; and 200 μl of purified acmA′ was added to those cells and incubated at 30°C for 2 h. The mixture was then centrifuged again at 2,000 g for 10 min and the cell pellet washed three times with 1 ml of 1×PBS each time. The binding was then analyzed by ELISA and immunofluorescence microscopy.
ELISA and immunofluorescence microscopy Control L. lactis cells and cells mixed with acmA′ were fixed with 4% (w/v) paraformaldehyde for 20 min at room temperature. The fixed cells were then washed three times with 1×PBS. Cells were then incubated with 3% BSA in PBS for 30 min at room temperature to block nonspecific binding. After washing with 1×PBS, the cells were centrifuged and the pellet resuspended in 500 μl of primary (anti-His) antibody solution (diluted in 1% BSA) and incubated for 60 min at room temperature. Rabbit AntiVP1 antibodies were used as primary antibodies to detect the binding of fusion proteins (AcmA/A1, AcmA/A3). The cells were then washed three times with 1×PBS before incubation with the secondary antibody [horseraddish peroxidase (HRP)-conjugated anti-mouse antibodies diluted at 1:500 in 1% BSA] at room temperature for 1 h. The cells were then washed three times with 1×PBS and finally resuspended in 200 μl of 1% PBS. Then, 10 μl of the suspension was loaded into the wells of an ELISA plate, followed by 50 μl of BM blue. The plate was then incubated at room temperature for 20 min before the optical density at 490 nm (OD 490 ) was measured.
For immunofluorescence microscopic observation, cells were similarly prepared as for ELISA, except that the cells were initially placed on chamber slides precoated with poly-L-lysine and incubated for 15 min before being fixed with 4% paraformaldehyde. Cells were also incubated with 3% BSA in PBS for 30 min at room temperature (to block nonspecific binding) and washed with 1×PBS. The fixed cells were then labeled with primary (anti-His) antibodies. The slide was then washed with 1×PBS and incubated with rhodamin anti-mouse secondary antibody (diluted at 1:200 in 1% BSA) at room temperature for 1 h. This was followed by washing three times with 1×PBS, air drying and mounting in an antifading agent (Fluoroguard, BioRad). The labeled slides were then analyzed by immunofluorescence microscopy (DMRA fluorescence microscope; Leica, Switzerland) fitted with filters (excitation 550 nm, emission 570 nm). Images were observed under a 100× oilimmersion objective. Images were taken with a COHU CCD camera and analyzed with Leica Q Fluoro-pro Imaging software and Adobe Photoshop software.
Stability studies
L. lactis cells mixed with AcmA/A1 and AcmA/A3 were allowed to stand at 4°C and samples were taken for ELISA every 24 h, up to 120 h.
Results
Construction of pSVac and transformation into competent E. coli.
The pRSET vectors are pUC-derived vectors designed for high-level protein expression and purification from cloned genes in E. coli. The plasmid includes an ATG translation inititation codon, a poly-His tag, a transcript-stabilizing sequence, a strong T7 promoter, an anti-express epitope and the enterokinase cleavage recognition sequence. Doubledigestion with the restriction enzymes PstI and HindIII showed that the small 255-bp repeat sequence of the Cterminal region of the cell wall-binding protein AcmA was successfully cloned in-frame with the T7 promoter downstream of the His tag sequence of the pRSETC vector. Figure 1 shows a map of the newly constructed vector, pSVac. Transformed cells were selected on chloramphenicol plates after overnight incubation.
Construction of pSVacA1 and pSVacA3
The gel-purified PCR products of the A1 and A3 regions of the VP1 gene were digested with XhoI and PstI. The pSVac surface display expression vector was treated with the same restriction enzymes to generate compatible ligation sites. Recombinant clones pSVacmA1 and pSVacmA3 were then transformed into BL21(DE3)pLysS cells. Sequencing analysis of the recombinant constructs indicated that the A1 and A3 regions of the VP1 gene were successfully cloned in frame with the acmA gene in the pSVac vector.
Expression of AcmA′ and AcmA fusion proteins in E. coli BL21(DE3) pLysS
Total protein extracts of E. coliBL21(DE3) pLysS acmA′ and E. coliBL21(DE3) pLysS(pRSETC) were analyzed by SDS-PAGE and Western Blot (Fig. 2) . In protein extracts of E. coliBL21(DE3) pLysS acmA′, the 15-kDa AcmA′ fragment was observed, the size being approximately the same as the calculated size of AcmA′-Histag. This protein band reacted with the anti-His antibody in the Western blot, further indicating that the cell wall-binding fragment of the acmA gene from L. lactis was successfully expressed in E. coli. In order to investigate whether the acmA gene constructs could be expressed as fusion proteins, recombinant E. coli BL21(DE3)pLysS cells harboring each of the two constructs (pSVacA1, pSVacA3) were grown and induced. The BL21(DE3)pLysS (pSVacA1, pSVacA3) cell lysates showed immunoreactive protein bands of 28 kDa and 25 kDa respectively, which were the expected size of the recombinant proteins, whereas there was no band in the control cells (data not shown).
Binding of the cell wall C-terminal binding domain of the AcmA protein to the cell surface of Lactococcus Although the expression of foreign proteins in E. coli has been documented widely, the expression of the functionally active domain of the cell wall fragment of L. lactis for cell surface display has not been reported anywhere. The purified AcmA′ fragment was incubated with L. lactis and subjected to ELISA. A strong color response was observed in the wells containing the cells incubated with AcmA′, whilst the wells containing bacterial cells not incubated with AcmA′ remained colorless (Fig. 3) . Our calculation of protein-binding capacity showed that at least 10 μg of protein was bound to approximately 2×10 9 cells. In addition, no color response was observed with the E. coli control cells (data not shown). Therefore, this indicated that the AcmA′ expressed in E. coli has an active binding domain and has the capacity to dock onto the outer surface of the L. lactis cell wall. To further confirm these results, the cells were analyzed by immunofluorescence microscopy. The L. lactis cells incubated with AcmA′ were efficiently stained by rhodamine-labeled secondary antibody, whilst the nonincubated cells remained free from staining (Fig. 4) . Similar results were observed with other gram-positive bacteria, such as Lactobacillus spp and Bacillus spp, which allowed the docking of AcmA′ onto their cell surface (data not shown).
To investigate whether the AcmA/A1 and AcmA/A3 fusion proteins were able to be anchored and displayed on the L. lactis cell surface in a stable conformation, whole cell ELISA analysis was carried out. A positive color change was detected for the L. lactis cells incubated with AcmA/A1 and AcmA/A3 fusion proteins whereas no color change was seen for L. lactis cells only (Fig. 5) Stable docking of the AcmA/A1 and AcmA/A3 on the outer cell surface of L. lactis
The stability of fusion proteins (AcmA/A1, AcmA/A3) was studied for the duration of 5 days, taking into account the noninvasive and noncolonizing behavior of L. lactis cells. Results showed that there was no significant difference in the OD 490 values after a period of 5 days (Fig. 6 ).
Discussion
Bacterial surface displays receive considerable attention in the fields of vaccine delivery, whole cell adsorbents, biocatalysts and diagnostic tools. L. lactis is one of the grampositive bacteria that has the potential to be developed into a vaccine-delivery vehicle. Much research has been con- ducted to improve the expression systems in L. lactis, including the use of inducible and constitutive promoters, secretory and intracellular expression of heterologous antigen and presenting the antigenic epitope on the cell surface. Several bacterial and viral antigens and cytokines have been produced efficiently in L. lactis (Wells et al. 1993; Ribeiro et al. 2002; Bermudez 2003) .
Targeting antigens to the cell wall by anchoring a signal sequence has been shown to be most efficient for eliciting immunogenicity in mice, compared with cytoplasmic or secreted counterparts (Reveneau et al. 2002) . However, with the available cell surface systems, there is no control over the level of expression; and translocation is often a limiting step. The defect in cell wall-anchoring has also been shown to be governed by the level of sortase, a transpeptidase tethering the protein to the cell wall (Dieye et al. 2003) . In this study, we constructed a plasmid expression vector containing the sequences for a single repeat unit of the AcmA cell wall-binding protein of L. lactis. The protein was expressed in a simple recombinant organism and interestingly was found to maintained its capacity to anchor onto the cell surface of L. lactis and the surface of other lactic acid bacteria (LABs) such as Lactobacillus and Bacillus. This is in agreement with studies by Buist (1997) . Therefore, it is possible to clone epitopes, peptides or any antigenic determinants upstream of the anchor region of the plasmid and express the recombinant proteins before purification and docking onto the L. lactis cells. The purification step allows us to gauge the concentration of the protein and to provide this system with the advantage of controlling the dosage of antigens carried by the cells and presented orally.
Another advantage of this strategy is that it is not dependent on antibiotic resistance genes as markers, since the epitopes can be purified and presented to the outer surface of the cells. By having a system which is not based on antibiotic resistance markers, the food-grading system may be better accepted by potential consumers. The carrier lactococcal cells can be a wild-type strain isolated from an environment friendly to the host organism. Another possibility is perhaps to have the simultaneous display of two different epitopes on the cell surface, using this strategy. It has been reported that, in the case of presenting antigenic determinants, sometimes more than one determinant is necessary to elicit an immunogenic response. We are at the moment trying to establish the display of viral epitopes as single and simultaneous representations on the cell surface of L. lactis and studying its feasibility and immunogenicity levels. Instability of surface proteins is generally a serious problem (Kobayashi et al. 2002) . Our stability assay indicated that the fusion proteins (AcmA/A1, AcmA/A3) were stably docked onto the cell surface of L. lactis for at least 5 days.
In order to show that the newly developed anchoring system can display immunogens on the L. lactis cell surface, we cloned the A1 and A3 epitopes of the VP1 protein of EV71 upstream of acmA in the pSVac vector. A positive color response was found for L. lactis cells incubated with AcmA/A1 and AcmA/A3 fusion proteins, whereas no color response was seen for wild-type L. lactis. The results strongly indicated not only the stable expression of the fusion proteins but also the retention of a biologically active conformation of the A1 and A3 regions of the VP1 protein. The results indicate that viral capsid proteins (VP1 protein of EV71) can be displayed on the cell surface and that this cell surface display system can be used in various applications. The newly developed surface display systems based on cell wall-binding domains of acmA genes have the potential to be used as oral vaccine delivery systems. The anchoring of the VP1 protein on the cell surface of lactococcal cells is advantageous because it provides adjuvant activity that could enhance the immunological response of hosts.
We are also attempting to clone other LAB cell wallbinding proteins into different expression systems and study their docking behavior on L. lactis and other LABs. This represents a system for developing LABs as vehicles for the oral administration of vaccine through food and water, which would be attractive because of its safety and the absence of immunosuppression.
In the work reported here, we developed the strategy for displaying antigenic determinants on the cell surface of L. lactis. This method is also applicable for presenting peptides or epitopes on the cell surface of L. lactis and other LABs for other useful purposes, such as biosensors and the delivery of pharmaceutical and nutraceutical products.
